Lexaria Bioscience Corp. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2024-04-26

Reporting Person: Baxter Nicholas W (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-26	Stock Options	$2.36	A	5000	Acquired	2029-04-26	Common Shares (5000)	Direct

Security	Shares	Ownership
common shares	11000	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (1500)	1500	Direct
Stock Options	$3	2026-06-08	Common Shares (5000)	6500	Direct
Stock Options	$3	2026-09-01	Common Shares (1900)	8400	Direct
Stock Options	$3.39	2027-03-08	Common Shares (3400)	11800	Direct
Stock Options	$1.96	2027-10-12	Common Shares (18200)	30000	Direct
Stock Options	$0.87	2028-07-25	Common Shares (5000)	35000	Direct

F1: Repriced from $5.31 pursuant to shareholder approval received May 9, 2023

F2: Repriced from $7.08 pursuant to shareholder approval received May 9, 2023

F3: Repriced from $6.23 pursuant to shareholder approval received May 9, 2023